| Date Filed | Type | Description |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/27/2022 |
4
| Elefant Dov (CFO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 422,000 options to buy
@ $0.55, valued at
$232.1k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| Elefant Dov (CFO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Bought 7,407 shares
@ $1.35, valued at
$10k
|
|
| 06/08/2020 |
4
| Elefant Dov (CFO) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Bought 4,348 shares
@ $1.145, valued at
$5k
Bought 2,174 options to buy
@ $1.2075, valued at
$2.6k
|
|
| 03/05/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |